Researchers discover protein complex that promotes cancer growth
Disruption of complex hinders cancer growth without harming normal cells
2021-06-28
(Press-News.org) A discovery by a team of researchers, led by a Geisinger professor, could yield a potential new treatment for breast cancer.
In a study published this month in Cell Reports, the team used small molecules known as peptides to disrupt a complex of two proteins, RBM39 and MLL1, that is found in breast cancer cells but not in normal cells.
The research team discovered that the abnormal interaction between RBM39 and MLL1 is required for breast cancer cells to multiply and survive. The team developed non-toxic peptides that prevent these proteins from interacting in breast cancer cells, disrupting their growth and survival.
"Because these proteins do not interact in normal cells, the peptides we developed are not harmful to them," said Anne M. Moon, M.D., Ph.D., professor at Geisinger's Department of Molecular and Functional Genomics and senior author of the study. "This offers promise for future non-toxic cancer treatment."
Further laboratory tests are needed before the treatment could be trialed in humans, Moon said.
INFORMATION:
Geisinger's cancer research also includes the MyCode Community Health Initiative, which returns clinically relevant results to participants at increased genetic risk for cancer, including breast, ovarian and colon cancers. The National Cancer Institute recently awarded Geisinger a 5-year, $3.6 million contract to study the role of genetic variation in cancer through the MyCode initiative.
Geisinger has an exciting research environment with more than 50 full-time research faculty and more than 30 clinician scientists. Areas of expertise include precision health, genomics, informatics, data science, implementation science, outcomes research, health services research, bioethics and clinical trials.
About Geisinger
Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes nine hospital campuses, a health plan with more than half a million members, a Research Institute, and the Geisinger Commonwealth School of Medicine. With nearly 24,000 employees and more than 1,600 employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn and Twitter.
ELSE PRESS RELEASES FROM THIS DATE:
2021-06-28
Anxiety, commonly termed as a feeling of fear, dread, and restlessness, is a perfectly normal reaction to stressful situations. However, a state of heightened anxiety, which is the reality for thousands of people who struggle to cope with these feelings, is called anxiety disorder. Anxiety disorder can invoke debilitating fear or apprehension, even without any immediate threat. Though intensive research over the years has yielded a plethora of information, and effective drugs like selective serotonin reuptake inhibitors have been used to alleviate this condition, a lot remains to be understood about this complex condition and ...
2021-06-28
The first two COVID-19 vaccines authorized for emergency use by the Food and Drug Administration (FDA) employed a technology that had never before been used in FDA-approved vaccines. Both vaccines performed well in clinical trials, and both have been widely credited with reducing disease, but concerns remain over how long immunity induced by the new vaccine technology will last.
Now, a study from researchers at Washington University School of Medicine in St. Louis, published June 28 in the journal Nature, has found evidence that the immune response to such vaccines is both strong and potentially long-lasting. Nearly four months after the first dose, people who received the Pfizer vaccine still had so-called germinal centers in their lymph nodes churning out ...
2021-06-28
The use of transparent masks during communication increases comprehension of speech by about 10% for people with hearing loss and people with normal hearing, according to a study published in the journal Ear and Hearing.
The study was conducted at the University of Texas in Dallas (USA), with the participation of Regina Tangerino, a professor at the University of São Paulo's Bauru Dental School (FOB-USP) in Brazil, and with support from São Paulo Research Foundation - FAPESP.
"Our findings show that wearing a transparent mask can facilitate communication for everyone, ...
2021-06-28
Hotels that opened their doors to homeless people in their community during lockdown generated greater positive word-of-mouth marketing than those that offered free accommodation to frontline healthcare workers, finds new University research.
However, despite the positive impact on tourists' intentions to share the good news story, the immediate impact on intention to book a visit was the reverse, with people less inclined to book a stay at a hotel that had housed homeless people.
Researchers at the Universities of Bath and Southampton were struck by news reports of the 'heart-warming initiatives' to offer free accommodation and wanted to investigate how they compared in terms of business benefit to the tourism sector.
"Our study found that hotels that ...
2021-06-28
A global leading cause of death today is a class of dreaded disorders called cardiovascular diseases (CVD), which are ailments of the heart and blood vessels, such as arrhythmia, stroke, coronary artery diseases, cardiac arrest, and so on. The causes for each CVD are different and can be genetic or lifestyle related; but one key risk factor is hypertension, also known as high blood pressure (BP). For instance, as a recent paper published in Chinese Medical Journal notes, in 2017, hypertension was a factor in over 2.5 million deaths in China alone, 95.7% of which were due to CVD.
In this paper, Dr. Jing Liu, expert in the epidemiology of cardiovascular diseases ...
2021-06-28
Scientists at the University of Southampton have found that a marine invasive species - a sea squirt that lives on rocky shores - could spread along 3,500 kilometres of South American coastline if climate change or human activities alter sea conditions.
The researchers - working with colleagues at Pontificia Universidad Católica de Chile; Flinders University, Australia; University of Johannesburg and Rhodes University, South Africa - analysed the creature's DNA and used predictive modelling to identify regions it could move to and thrive in.1 Findings are published in the journal PNAS.
The team took a multidisciplinary approach to predict the potential distribution of a species that is currently restricted. Studying species with small distributions ...
2021-06-28
A new approach to molecular drug design has yielded a highly promising bladder cancer drug, which induced rapid shedding of tumour cells and resulted in a significant reduction in tumour size when used in clinical trials.
These potent effects were seen in patients with non-muscle invasive bladder cancer (NMIBC) and the treatment was shown to be safe, as no drug-related side effects were observed.
The exciting research involved a collaborative group of scientists from Trinity College Dublin, Charles University and Motol Hospital (Prague), Lund University, and startup company Hamlet Pharma. The study has just been published in leading journal Nature Communications.
Bladder cancer - a global killer
Bladder cancer is the fifth most common malignancy in Europe (and the ...
2021-06-28
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26. Based on initial observations, the drug candidate is well tolerated and the first therapeutic effects have been demonstrated, to be confirmed as the trial continues.
Crigler-Najjar syndrome is a rare genetic liver disease characterized by abnormally high levels of bilirubin in the blood (hyperbilirubinemia). This accumulation of bilirubin is caused by a deficiency of the UGT1A1 enzyme, responsible for transforming bilirubin into a substance that can be eliminated by the ...
2021-06-28
ATLANTA - JUNE 28, 2021 - A new study finds evidence for adverse effects of the COVID-19 pandemic on declines in cancer detection and surgical treatments. The study, appearing in JNCI: The Journal of the National Cancer Institute, finds a 10.2% decline in real-time electronic pathology reports from population-based cancer registries in 2020 compared with those in 2019.
This study observation period, through December 2020, is one of the longest to date for evaluating the effects of the COVID-19 pandemic on cancer-related trends. To learn more about the indirect effects of the pandemic on cancer care, investigators led by Robin Yabroff, PhD, MBA of the American ...
2021-06-28
Up to 7 million people each year receive care in an emergency department (ED) for chest pain, a symptom of a potential heart condition. Over 80 percent of chest pain patients, however, ultimately have no evidence of cardiovascular disease or acute coronary syndrome. To disincentivize patients from over-utilizing costly care, insurers and employers are increasingly opting for high-deductible health plans (HDHPs) that require significant out-of-pocket spending before coverage begins. Researchers from Brigham and Women's Hospital and Harvard Pilgrim Health Care Institute investigated whether ...
LAST 30 PRESS RELEASES:
[Press-News.org] Researchers discover protein complex that promotes cancer growth
Disruption of complex hinders cancer growth without harming normal cells
